National Centre for Cell Science, Ganeshkhind, Pune, Maharashtra, India.
Department of Microbiology and Immunology, Columbia University, New York, NY, USA.
Methods Mol Biol. 2022;2410:433-461. doi: 10.1007/978-1-0716-1884-4_23.
Search for an efficacious antileishmanial vaccine has led to clinical trials of numerous vaccine candidates in the past few decades. As no promising candidate has emerged from these studies, novel vaccine modalities and vaccine assessment techniques are still emerging for antileishmanial vaccine development. Briefly, this chapter discusses: (a) history and timeline of antileishmanial vaccine development; (b) techniques utilized for developing whole-parasite and subunit-based antileishmanial vaccine formulations, and (c) immunogenicity and post-challenge protective efficacy assessment of vaccine candidates.
寻找有效的抗利什曼病疫苗导致了过去几十年中对众多疫苗候选物的临床试验。由于这些研究中没有出现有前途的候选物,因此仍在不断开发新的疫苗模式和疫苗评估技术用于抗利什曼病疫苗的开发。简要地,本章讨论了:(a)抗利什曼病疫苗开发的历史和时间表;(b)用于开发全寄生虫和亚单位疫苗制剂的技术;和(c)候选疫苗的免疫原性和接种后保护效力评估。